WENDALL D WIERENGA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WENDALL D WIERENGA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WENDALL D WIERENGA. WENDALL D WIERENGA is Director in APRICUS BIOSCIENCES, INC. ($APRI) and Director in XENOPORT INC ($XNPT) and Director in CYTOKINETICS INC ($CYTK) and Director in Ocera Therapeutics, Inc. ($TZYM) and Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and Director in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX).
Latest Insider Trading Transactions of WENDALL D WIERENGA
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, CNCE, CRNX, CYTK, TZYM, SEEL, XNPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 24.32 | 10,000 | 243,200 | 10,000 | |
| May 13 2021 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Grant | A | 0.00 | 5,000 | 0 | 5,920 | 920 to 5.9 K (+543.48 %) |
| Apr 05 2021 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Grant | A | 24.44 | 409 | 9,996 | 920 | 511 to 920 (+80.04 %) |
| Jun 22 2020 | CRNX | Crinetics Pharmace ... | WIERENGA WENDALL | Director | Option Exercise | A | 23.23 | 12,500 | 290,375 | 12,500 | |
| May 14 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 21.61 | 20,000 | 432,200 | 20,000 | |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | M | 11.04 | 6,666 | 73,593 | 0 | |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | M | 8.64 | 3,333 | 28,797 | 0 | |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Sell | S | 16.00 | 6,666 | 106,656 | 0 | 6.7 K to 0 (-100.00 %) |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Buy | M | 11.04 | 6,666 | 73,593 | 6,666 | 0 to 6.7 K |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Sell | S | 16.00 | 3,333 | 53,328 | 0 | 3.3 K to 0 (-100.00 %) |
| Apr 29 2020 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Buy | M | 8.64 | 3,333 | 28,797 | 3,333 | 0 to 3.3 K |
| Apr 29 2020 | CRNX | Crinetics Pharmace ... | WIERENGA WENDALL | Director | Option Exercise | M | 0.73 | 25,329 | 18,490 | 12,500 | |
| Apr 29 2020 | CRNX | Crinetics Pharmace ... | WIERENGA WENDALL | Director | Buy | M | 0.73 | 25,329 | 18,490 | 99,846 | 74.5 K to 99.8 K (+33.99 %) |
| Jun 25 2019 | CRNX | Crinetics Pharmace ... | WIERENGA WENDALL | Director | Option Exercise | A | 23.24 | 12,500 | 290,500 | 12,500 | |
| May 17 2019 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 10.68 | 20,000 | 213,600 | 20,000 | |
| Jun 18 2018 | CNCE | CONCERT PHARMACEUT ... | WIERENGA WENDALL | Director | Option Exercise | A | 19.59 | 10,000 | 195,900 | 10,000 | |
| May 17 2018 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 9.45 | 20,000 | 189,000 | 20,000 | |
| Jan 08 2018 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 2.11 | 35,000 | 73,850 | 35,000 | |
| Jan 04 2018 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 8.75 | 5,714 | 49,998 | 5,714 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 2.26 | 12,500 | 28,250 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 3.76 | 10,000 | 37,600 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 7.84 | 10,000 | 78,400 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | D | 13.25 | 20,000 | 265,000 | 0 | |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 12,500 | 19,000 | 0 | 12.5 K to 0 (-100.00 %) |
| Dec 11 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Sell | D | 1.52 | 5,000 | 7,600 | 0 | 5 K to 0 (-100.00 %) |
| Jun 22 2017 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 12,500 | 0 | 17,500 | 5 K to 17.5 K (+250.00 %) |
| Jun 19 2017 | CNCE | CONCERT PHARMACEUT ... | WIERENGA WENDALL | Director | Option Exercise | A | 13.29 | 10,000 | 132,900 | 10,000 | |
| May 22 2017 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 14.25 | 20,000 | 285,000 | 20,000 | |
| Jan 06 2017 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 11,250 | 0 | 15,373 | 4.1 K to 15.4 K (+272.86 %) |
| Jan 04 2017 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 12.40 | 4,032 | 49,997 | 4,032 | |
| Oct 03 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.34 | 8,868 | 3,000 | 41,228 | 32.4 K to 41.2 K (+27.40 %) |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 0.00 | 5,000 | 0 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 4.35 | 15,000 | 65,250 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 6.04 | 15,000 | 90,600 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 4.57 | 15,000 | 68,550 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 6.17 | 15,000 | 92,550 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | D | 6.18 | 15,000 | 92,700 | 0 | |
| Jul 06 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Sell | U | 7.03 | 38,998 | 274,156 | 0 | 39 K to 0 (-100.00 %) |
| Jul 01 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.40 | 7,510 | 3,000 | 32,360 | 24.9 K to 32.4 K (+30.22 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | D | 25.48 | 27,000 | 687,960 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Sell | D | 99.25 | 794 | 78,805 | 0 | 794 to 0 (-100.00 %) |
| Jun 15 2016 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | A | 2.26 | 12,500 | 28,250 | 12,500 | |
| Jun 10 2016 | CNCE | CONCERT PHARMACEUT ... | WIERENGA WENDALL | Director | Option Exercise | A | 12.96 | 10,000 | 129,600 | 10,000 | |
| May 20 2016 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 7.61 | 20,000 | 152,200 | 20,000 | |
| May 19 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| May 19 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | A | 4.35 | 15,000 | 65,250 | 15,000 | |
| May 19 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 19 2016 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Buy | M | 0.00 | 5,000 | 0 | 38,998 | 34 K to 39 K (+14.71 %) |
| Apr 07 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Grant | A | 0.58 | 4,850 | 2,813 | 24,850 | 20 K to 24.9 K (+24.25 %) |
| Jan 06 2016 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 10.00 | 4,375 | 43,750 | 4,375 | |
| Jan 05 2016 | APRI | APRICUS BIOSCIENCE ... | WIERENGA WENDALL | Director | Option Exercise | A | 0.97 | 25,000 | 24,250 | 25,000 | |
| Jun 24 2015 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Buy | P | 3.71 | 5,000 | 18,550 | 5,000 | 0 to 5 K |
| Jun 22 2015 | TZYM | Ocera Therapeutics ... | WIERENGA WENDALL | Director | Option Exercise | A | 3.76 | 10,000 | 37,600 | 10,000 | |
| Jun 15 2015 | CNCE | CONCERT PHARMACEUT ... | WIERENGA WENDALL | Director | Option Exercise | A | 16.42 | 10,000 | 164,200 | 10,000 | |
| Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
| Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | WIERENGA WENDALL | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
| May 21 2015 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| May 21 2015 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | A | 6.04 | 15,000 | 90,600 | 15,000 | |
| May 21 2015 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 21 2015 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Buy | M | 0.00 | 5,000 | 0 | 33,998 | 29 K to 34 K (+17.24 %) |
| May 21 2015 | CYTK | CYTOKINETICS INC | WIERENGA WENDALL | Director | Option Exercise | A | 6.21 | 20,000 | 124,200 | 20,000 | |
| May 12 2015 | XNPT | XENOPORT INC | WIERENGA WENDALL | Director | Buy | P | 5.63 | 5,000 | 28,169 | 28,998 | 24 K to 29 K (+20.84 %) |
Page: 1